ASX:VTI

Visioneering Technologies (VTI) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Visioneering Technologies

Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal one-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.

VTI Stock News Headlines

AI “wealth window” is closing June 25th
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
AI “wealth window” is closing June 25th
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
VTI.AX - Visioneering Technologies, Inc.
Wingtech Technology
SCHD Vs. VTI: Which ETF Is The Better Buy?
Visioneering Technologies Inc
VTI, KO, COST, ACN: Large Inflows Detected at ETF
VTI: Risk/Reward Appears Reasonable Again
See More Headlines
Receive VTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Visioneering Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-3,450,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.67 million
Book Value
A$0.11 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.65
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Brian D. Lane CPA (Age 62)
    Chief Operating & Chief Financial Officer
    Comp: $451.21k
  • Dr. Kuang-Mon Tuan FAAO
    Ph.D., Chief Medical Officer
  • Dr. Juan Carlos Aragon
    CEO & Executive Director
  • Dr. Richard A. Griffin
    Founder & Medical Adviser
  • Ms. Layna L. Mendlinger
    Global Head of Marketing
  • Ms. Leanne Ralph AAICD
    ACIS, BBus, Company Secretary

This page (ASX:VTI) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners